Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)
China · Delayed Price · Currency is CNY 3.750
-0.010 (-0.27%)
Jan 30, 2026, 3:00 PM CST
SHA:600165 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -310.34 | -538.91 | -464.71 | -141.48 | -166.09 | 20.91 | Upgrade |
Depreciation & Amortization | 127.44 | 127.44 | 137.85 | 122.84 | 59.85 | 14.58 | Upgrade |
Other Amortization | 1.16 | 1.16 | 1.12 | 0.85 | 0.87 | 0.15 | Upgrade |
Loss (Gain) From Sale of Assets | 0.95 | 0.95 | -0.21 | 0.06 | -2.1 | - | Upgrade |
Asset Writedown & Restructuring Costs | 119.99 | 119.99 | 185.07 | 23.66 | - | 2.14 | Upgrade |
Loss (Gain) From Sale of Investments | 83.26 | 83.26 | -34.18 | -34.96 | -39.77 | -41.75 | Upgrade |
Provision & Write-off of Bad Debts | 0.21 | 0.21 | -1.16 | 0.12 | -0.27 | -0.03 | Upgrade |
Other Operating Activities | -286.98 | 172.1 | 127.08 | 91.07 | 64.25 | 24.48 | Upgrade |
Change in Accounts Receivable | -18.01 | -18.01 | -25.44 | -16.69 | 4.58 | -18.69 | Upgrade |
Change in Inventory | -1.7 | -1.7 | 35.33 | 60.58 | -121.37 | 22.6 | Upgrade |
Change in Accounts Payable | -24.15 | -24.15 | 60.37 | -54.5 | 181.53 | -57.68 | Upgrade |
Change in Other Net Operating Assets | -5.5 | -5.5 | 2.32 | -1.12 | - | -4.62 | Upgrade |
Operating Cash Flow | -315.72 | -85.19 | 23.15 | 53.14 | -17.93 | -41.06 | Upgrade |
Operating Cash Flow Growth | - | - | -56.43% | - | - | - | Upgrade |
Capital Expenditures | -48.67 | -6.2 | -57.68 | -59.31 | -240.39 | -732.9 | Upgrade |
Sale of Property, Plant & Equipment | -0 | 1.44 | 4.21 | - | 2.6 | - | Upgrade |
Cash Acquisitions | - | - | -2.21 | -498 | -32 | -47.68 | Upgrade |
Divestitures | - | - | - | - | 250.07 | 89.31 | Upgrade |
Investment in Securities | - | - | - | 14.11 | 14.11 | 14.11 | Upgrade |
Other Investing Activities | - | - | - | - | - | 0.63 | Upgrade |
Investing Cash Flow | -48.67 | -4.76 | -55.68 | -543.2 | -5.61 | -676.52 | Upgrade |
Long-Term Debt Issued | - | 64.25 | 275.36 | 1,426 | 729.6 | 1,018 | Upgrade |
Total Debt Issued | 311.37 | 64.25 | 275.36 | 1,426 | 729.6 | 1,018 | Upgrade |
Long-Term Debt Repaid | - | -61.76 | -248.4 | -929.07 | -746.06 | -525.1 | Upgrade |
Total Debt Repaid | -62.86 | -61.76 | -248.4 | -929.07 | -746.06 | -525.1 | Upgrade |
Net Debt Issued (Repaid) | 248.51 | 2.49 | 26.96 | 496.53 | -16.46 | 492.5 | Upgrade |
Common Dividends Paid | -5.01 | -3.65 | -23.25 | -53.14 | -55.29 | -46.74 | Upgrade |
Other Financing Activities | 119 | 76.72 | 7.99 | - | - | 323.46 | Upgrade |
Financing Cash Flow | 362.51 | 75.56 | 11.7 | 443.39 | -71.75 | 769.21 | Upgrade |
Foreign Exchange Rate Adjustments | 0.19 | 0.75 | 0.55 | 2.53 | -0.69 | -0.12 | Upgrade |
Net Cash Flow | -1.69 | -13.64 | -20.28 | -44.13 | -95.98 | 51.51 | Upgrade |
Free Cash Flow | -364.39 | -91.39 | -34.53 | -6.17 | -258.32 | -773.96 | Upgrade |
Free Cash Flow Margin | -74.65% | -26.47% | -12.09% | -0.91% | -103.86% | -649.76% | Upgrade |
Free Cash Flow Per Share | -0.53 | -0.13 | -0.05 | -0.01 | -0.38 | -1.15 | Upgrade |
Cash Income Tax Paid | 23.66 | 12.55 | 9.8 | -21.66 | 19.73 | 5.99 | Upgrade |
Levered Free Cash Flow | -12.17 | 164.54 | 42.5 | 64.39 | 2.8 | -210.6 | Upgrade |
Unlevered Free Cash Flow | 23.3 | 255.39 | 131.57 | 121.81 | 22.35 | -196.14 | Upgrade |
Change in Working Capital | -51.4 | -51.4 | 72.3 | -9.01 | 65.33 | -61.53 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.